Expression cloning of a human Fc receptor for IgA by unknown
IgA fulfills a critical protective role against the constant en-
vironmental insults encountered at mucosal surfaces (1).
Although the mechanism of protection is not completely
defined, the IgAmediated mucosal immune response may be
at least partially manifested through binding of IgAcoated
targets to Fc receptors (FcaR) on effector cells. In particular,
human monocytes, macrophages, neutrophils, and myeloid
cell linesexpress cell surface FcaR (2-5) that havebeen shown
to mediate effector functions such as phagocytosis (6-8),
antibody-dependent cell cytotoxicity (9), and inflammatory
mediator release (10, 11). Other studies indicate that the human
myeloid cell FcaR is a protein of rv60 kD (12, 13), which,
upon deglycosylation, can be resolved to two protein cores
of 32 and 36 kD (13).
Recently, a mAb (My43) was developed that inhibited
binding of IgA and phagocytosis of IgA-coated targets, and
that coulddirectly trigger phagocytosis and superoxide produc-
tion by human myeloid cellsand cell lines(14). Furthermore,
the mAb failed to bind to human lymphocytes, consistent
with the likelihood that My43 binds to a myeloid cell-specific
IgA receptor. In this report, we describe the use of.the My43
mAb to isolate a clone from a myeloid cell line cDNA library
that directs the expression of a cell surface molecule with
IgA binding specificity.
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Summary
IgA, the predominant isotype in secretions, mediates the neutralization and removal ofenvironmental
antigens from mucosal sites. Although cell surface receptors for the Fc region of IgA (FcaR)
have been implicated in a variety ofimmune effector mechanisms, the molecular features ofFcaR
remain only marginally characterized. In this report, we describe the isolation of a clone from
a myeloid cell line cDNA library that directs the expression of a cell surface molecule with IgA
binding specificity. The cDNA encodes a peptide of Mr 30,000 including a putative trans-
membrane region with features atypical ofconventional membrane-anchored proteins. Databank
searches indicate that the human myeloid cell FcaR sequence is unique, is a member of the
immunoglobulin gene superfamily, and is related to Fc receptors for IgG (FcyRI, II, and III)
and IgE (Fcc-RI) .
Cells.
￿
The monocyte-like cell line U937 (15) was maintained
in continuous culture in RPMI 1640 supplementedwith 10% FCS.
Differentiation was induced by culturing the cells overnight in the
presence of 5 ng/mlofPMA (Sigma Chemical Co., St. Louis, MO).
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Monocytes and polymorphonuclear leukocytes were purified from
heparinized peripheralblood by centrifugation through isolymph
(Gallard-SchlesingerChemical Mfg. Corp., Carle Place, NY), fol-
lowed by centrifugal elutriation, using a centrifuge (6 M/E;
Beckman Instruments, Inc., Fullerton, CA) equipped with a JE-5.0
rotor. The resulting fractions were analyzed by Wright-Giemsa
staining of cytocentrifuge preparations.
Human T lymphocytes were purified from tonsils by E-rosetting
with 2-aminoethylisothio-uronium bromide (AET)'-treated SRBC,
followed by Ficoll-Hypaque density gradient centrifugation (16).
Tonsillar B lymphocytes were isolated from the leukocyte layer
resulting from AETSRBC and Ficoll separation, with further deple-
tion ofnon-B cells achieved by treatment with antibody and com-
plement using Lympho-Kwik B (One Lambda, Los Angeles, CA).
Purified preparations ofT and B cells were maintained in a medium
consisting ofRPMI 1640/10% FCS (HyClone Laboratories, Logan,
UT), sodium pyruvate (1 mM), nonessential aminoacids (100 mM),
penicillin/streptomycin (100 U/ml per 100 Etg/ml), L-glutamine (2
mM), 2-ME (50 mM), and fungizone (1:2,000; Gibco Laborato-
ries, Grand Island, NY). B cells or T cells were cultured either
alone or, as indicated, in the presence of Con A (20 lzg/ml; Sigma
Chemical Co.), PWM (40 ug/ml; SigmaChemical Co.), or PMA
(5 ng/ml) plus ionomycin (500 ng/ml; Calbiochem-Behring Corp.,
San Diego, CA). After a 16-h incubation, cells were harvested for
RNA preparation as described below.
cDNA Expression andImmunoselection.
￿
cDNA was synthesized
from polyadenylated RNA extracted from 12-h PMA-stimulated
U937 cells according to standard protocols (17). The cDNA was
'Abbreviations used in this paper: AET, 2-aminoethylisothio-uronium
bromide; GPI, glycosyl-phosphatidyl inositol; OE, ox erythrocyte; PLC,
phospholipase C.
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expressionplasmid (18), using nonselfcomplementary linkers con-
taining Bg1II restriction sites.
The cDNA library representing 600,000independent clones was
amplified by growing bacteria in liquid cultures in the presence
of chloramphenicol overnight, then plating at a density of 5,000
colonies per plate. Colonies were scraped from plates and pooled,
and plasmid DNA was recovered and purified by alkaline lysis and
CsCl gradient centrifugation (19). Plasmid DNA from the cDNA
library was used to transfect a subconfluent layer ofmonkey COS-7
cells using DEAF dextran followed by chloroquine treatment, as
described (20). FCaR` cells were selected by incubation in the
My43 anti-FcciR mAb (14), followed by panning on anti-IgM-
coated plates according to established procedures (21). Episomal
DNA was prepared from the panned cells, amplified, and rein-
troduced into COS cells. After three such rounds of transfection
(two DEAE dextran rounds and one protoplast fusion round) and
immunoselection, 96 individual plasmid-transformed bacterial colo-
nies were grown, collected into 20 pools, and pooledplasmids were
extracted by alkaline lysis (19) and transfected into COS cells. Posi-
tive pools were selected by flow cytometric analysis of anti-FCaR
(My43) binding to transfected cells. Individual clones containing
FcotR cDNA were isolated from positive pools. One of these,
pHuFcciR, was selected for characterization.
Sequence Analysis.
￿
DNA sequencing was performed on both
strands as previouslydescribed (22). For alignment analysis, residues
constituting the two extracellular Ig domains were aligned with
other FcR Ig domains using computerized models (NBRF pro-
gram ALIGN[23]) and by eye. The MD data matrix was used with
a bias of +6, and a gap penalty of 6 was used. Scores are the SD
for the indicated pair of aligned sequences vs. the average scores
from 100 randomized alignments of the same pair of sequences.
Immunoglobulins.
￿
The My43 anti-FcaR murine hybridoma cell
line (IgM, u) was maintained in Dulbecco's medium containing
10% FCS. Supernatants were collected at twice-weekly intervals,
sterile filtered, and stored at 4°C. Human IgAl and IgGI parapro-
teins were purified as previously described (14). F(ay)2 anti-ox
erythrocytes (OE) was prepared from rabbit anti-OE IgG (Cooper-
Biomedical, Inc., Malvern, PA) by pepsin cleavage and passage
through protein A-Sepharose CL-6B.
Flow Cytometry.
￿
For anti-FcaRbinding experiments, cells were
incubated with hybridoma culture supernatants containing either
My43 mAb or a nonspecific isotype control mAb. After 30 min
at 4°C, cells werewashed and incubated with fluoresceinated second
antibody (affinity-purified goat anti-murine IgM, It chain specific
[F(ab')2]) for 30 min at 4°C, then washed. For IgA binding ex-
periments, cells were stained with 12.5 Wg/ml FITC-conjugated
human myeloma IgAl or IgGI (30 min at 4°C). All antibody dilu-
tions and washes were performed in PBS/0.1% BSA/0.05% so-
dium azide. Cellswere analyzed on a FACScan flow cytometer using
a logarithmic fluorescence intensity scale.
RosetteAssay.
￿
Conjugates ofIgA or IgG linked to anti-OE were
made by using the bifunctional reagent SPDP (Pharmacia Fine
Chemicals, Uppsala, Sweden) (24). IgA or IgG and F(ab'h anti-OE
(at 1-3 mg/ml) were treated separately with an eightfold molar
excess of SPDP for 2 h at 18°C. SPDP-treated anti-OE F(ab')2 was
dialyzed in PBS, pH 7.2, and SPDP-treated IgA and IgG were dia-
lyzed in 0.1 M acetate, 0.1 M NaCl, pH 4.5, treated with 0.02 M
dithiothreitol (30 min), and passed through a G25 Sephadex column
(Pharmacia Fine Chemicals), equilibrated in 0.1 M phosphate, 0.1 M
NaCl, pH 7.5. Equimolar amounts of the anti-OE F(ab')2 and I&A
orIgG were then mixedand incubated at 18°C for 4 h, after which
crosslinking was terminated with 2 mM iodoacetamide. Prepara-
tions contained <15% noncrosslinked Ig.
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Packed OE (10 pl) were mixed for 16 h at 10°C with 25 Al of
the F(ab')2 conjugates at concentrations previously determined to
give maximal rosette formation. Equal volumes ofcells (transfected
COS-7 or U937 cells) at 2 x 106/ml and a 1% suspension of
heteroantibody-coated OE were centrifuged together and incubated
on ice for 90 min. In some cases, cells were preincubated on ice
with human IgA, IgG, My43, or control IgM mAb before the
addition ofOE. Aftergentle resuspension, the percentageofrosette-
forming cells, defined as cells binding greater than four OE, was
determinedby counting a minimum of 200 cells in duplicate samples
using light microscopy.
Hybridization Techniques.
￿
TotalRNA was isolated from cells as
described (25), then subjected to oligo(dT)-cellulose chromatog-
raphy to purify polyadenylated RNA (19). The mRNA was sub-
jected to electrophoresis in a fonnaldehyde/1.2% agarose gel, blotted
by capillary flow onto a Nytran filter (Schleicher & Schnell, Inc.,
Keene, NH) (26), and hybridized for 16 h at 63°C in Starks hy-
bridization solution (50% formamide, 2x Denhardt's solution, 5x
SSC, 0.1% SDS, 50 mM KH2P04, 20 mM EDTA, 0.05%
N-lauroylsarcosine,150 dug sheared, denatured salmon sperm DNA
per ml) containing 'ZP-labeled antisense riboprobe transcribed from
the 5' portion (-430 bases) of pHuPcak. Washes were carried
out in 2x SSC, 0.1% SDS at 63°C. Dried filters were exposed
to Kodak X-Omat AR film for 2 d and developed.
Human placental genomic DNA was isolated as described (27)
and digested to completion with the indicated restriction en-
donucleases. 8 Ag of digested DNA was subjected to electropho-
resis on a 0.7% agarose gel, transferred to a Nytran filter, and hy-
bridized for 16 h at 42°C in Starks solution containing a
'2P-labeled 700-bp fragment encoding the 5' untranslated and ex-
tracellular coding region of FcaR. Hybridized blotswere washed
in 0.2x SSC, 0.1% SDS at 65°C, dried, and autoradiographed.
Results and Discussion
The My43 mouse mAb binds selectively to a cell surface
receptor for IgA on human myeloid cells. We used this mAb
as the basis for immunoselection of an FcaR cDNA clone,
using a modification of the technique previously described
by Seed and Aruffo (21). The U937 cell line represented a
convenient source ofmRNA for cDNA library construction,
since FcaR expression as measured by My43 binding is in-
ducible by PMA treatment. We found that maximal FcaR
cell surface expression occurred after 24 h in the presence of
PMA, suggesting that maximal mRNA levels are achieved
at an earlier time point. Thus, polyadenylated RNA was ex-
tracted from U937 cells treated for 12 h with PMA, and a
cDNA library was prepared in the pDC303 mammalian ex-
pression plasmid.
Purified plasmid DNA from the U937 cDNA library was
transfected into COS-7 cells, FcaRexpressing cellswere iso-
lated by panning with the My43 mAb, and plasmid DNA
was extracted from the immunoselected COS-7 cells. After
additional rounds of transfection and immunoselection, an
individual FcaR cDNA done was selected by flow cytometric
analysis of transfected COS cells using the My43 mAb. As
shown in Fig. 1 A, My43 bound to a subpopulation of COS
cellstransfected with pHuFmR, but failed to react with cells
transfeected with an insertless p12smid. An isotype control mAb
displayed onlybackground binding with both cell types (Fig.
1 B). Besides expressing a cell surface epitope recognizedbya
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Figure 1.
￿
Expression of FcaR cDNA in transfected cells. (A and B)
Anti-FcaR binding. Control plasmid (solid line) and pHuFcaR (dashed
line) transfected COS cells were stained with either My43 or a murine
IgMisotypecontrolandanalyzed by flowcytometry .(Cand D) IgA binding.
Control plasmid andpHuFcotR transfected COS cells were stained with
human IgA-FITC or human IgG-FITC and analyzed by flow cytometry.
My43, these cells were also capable of binding IgA . Thus,
FcaRtransfected COS cells directly bound FITC-conjugated
human IgA (Fig. 1 C), but not human IgG-FITC (Fig. 1
D) . In contrast, controlCOS cells displayed only background
binding of either Ig isotype. The receptor exhibited the ex-
pected binding specificity, since IgAFITC binding was in-
hibited by unconjugated human IgA and byMy43, but not
byhumanIgGor an irrelevant murineIgMmAb (not shown) .
1667
￿
Maliszewski et al .
FcR* COS cells were treated for 30 min at 4°C with hybridoma su-
pernatants or purified Ig, or with medium alone. The cells were then
examined for ability to form rosettes with OE coated with human mye-
loma IgA, as described in Materials and Methods . Results show mean
and SD of duplicates .
FcaiR expression was also measured by the ability oftrans-
fected cells to form rosettes with IgA-coated OE (Fig. 2) .
COS cells transfected with pHuFcctR formed distinct ro-
settes when incubated in thepresence of human IgA-coated
Figure 2.
￿
IgAspecific rosette forma-
tion by transfected cells. COS cells were
transfected with pHuCFcctR plasmid
(A-E) and incubated with human IgA-
OE (A-D) or humanIgGI-OE (E), and
microscopically analyzed for rosettefor-
mation . In some cases, transfected cells
were incubated with "blocking" anti-
bodies before addition of OE: (B)
My43 ; (C)HuIgA; (D) HulgG . In F,
COS cells transfected with control
plasmid were incubated with IgA-OE .
+My43.66
I I J ;
,
+ Control mAb
L+ FITC ~- IqG-FITC
Table 1 . Inhibition
Rosette Formation
of FcciR'-COS Cell IgA
Antibody treatment Concentration Rosette-forming cells
SD
Medium - 10.6 (0.9)
My43 hybridoma
supernatant Undiluted 1.5 (1)
1:3 0.75 (0.75)
1:9 8.3 (0.25)
1:27 11.5 (0.15)
Control hybridoma
supematant Undiluted 11.4 (1)
Human IgA 2 mg/ml 0
666 ltg/ml 0.9
2221Ag/ml 6.2 (0.3)
74 Rg/ml 9.3 (1)
Human IgG 2 mg/ml 9.7 (0.05)B
AGG ATT CAG GCA CAG GAA GGG GAC TTf CCC ATG CCT TIC ATA TCT GCC AAA TCG AM CCT GTG ATT CCC TTG GAT GGA TCT GTG AAA ATC
￿
180
Arg Ile Gln Ala Gln Glu Gly Asp Phe Pro Met Pro Phe Ile Ser Ala Lys Ser Ser Pro Val Ile Pro Len Asp Gly Ser Val Lys Ile
￿
26
CAG
Gln
TGC
Cys
CAG
Gln
GGCACAGATCTrGGAACGAGACGACCTGCTGTCAGCACG ATG GAC CCC AAA CAG ACC ACC CTC CTG TGT CTT GTG CTC TGT CTG GGC CAG
￿
90
Met Asp Pro Lys Gln Thr Thr-Lou Lou Cys Lou Val Leu Cys LOU Gly Gln
￿
-5
GCC ATT CGT GAA GCT TAC CTG ACC CAG CTG ATG ATC ATA AAA AAC TCC ACG TAC CGA GAG ATA GGC AGA AGA CfG AAG TIT
￿
210
Ala Ile Arg Glu Ala Tyr Leu Thr Gln Lou Met Ile Ile Lys Asn Ser Thr Tyr Arg Glu Ile Gly Arg Arg Lou Lys Phe
￿
56
TGG AAT GAG ACT GAT CCT GAG TTC GTC ATT GAC CAC ATG GAC GCA AAC AAG GCA GGG CGC TAT CAG TGC CAA TAT AGG ATA GGG CAC TAC 360
Trp Asn Glu Thr Asp Pro Glu Phe Val Ile Asp His Met Asp Ala Asn Lys Ala Gly Arg Tyr Gln Cys Gln Tyr Arg Ile Gly His Tyr
￿
86
AGA ITC CGG TAC AGT GAC ACC CTG GAG CTG GTA GTG ACA GGC TTG TAT GGC AAA CCC TTC CTC TCT GCA GAT CGG GGT CTG GTG TTG ATG 450
Arg Phe Arg Tyr Ser Asp Thr Lou Glu l.eu Val Val Thr Gly Lou Tyr Gly Lys Pro Phe Lou Ser Ala Asp Arg Gly l.eu Val Lou Met 116
CCA GGA GAG AAT ATT
Pro Gly Glu Asn Ile
TCC CTC ACG
Ser Lou Thr
TCA GCA CAC ATC CCA TTT GAT AGA TTT TCA CTG GCC AAG GAG GGA GAA CTT TCT CTG CCA 540
Ser Ala His Ile Pro Phe Asp Arg Phe Ser Lou Ala Lys Glu Gly Glu Lou Ser Lou Pro 146
CAG CAC CAA AGT GGG GAA CAC CCG GCC AAC TTC TCT TTG GGT CCT GTG GAC CTC AAT GTC TCA GGG ATC TAC AGG TGC TAC GGT TGG TAC 630
Gln His Gln Ser Gly Glu His Pro Ala Asn Phe Ser Lou Gly Pro Val Asp Leu Asn Val Ser Gly Ile Tyr Arg Cys Tyr Gly Trp Tyr 176
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TGC
Cys
AGC
Ser
H C
200bp
AAC AGG AGC CCC TAC CTG TGG TCC TTC CCC AGT AAT GCC TTG GAG C r GTG OTC ACA GAC TCC ATC CAC CAA GAT TAC ACG ACG CAG AAC 120
Asn Arg Ser Pro Tyr Lau Trp Ser Phe Pro Ser Asn Ala Lou Glu L.eu Val Val Thr Asp Ser Ile His Oln Asp Tyr Thr Thr Gln Asn 206
TrG ATC CGC ATG GCC GTG GCA GGA CTG OTC CTC GTG OCT CTC TTG GCC ATA C1'G GTT GAA AAT TGG CAC AGC CAT ACG GCA CTG AAC AAG 810
LOU Ile Arg Met Ala Val Ala Gly Lou Val Lou Val Ala Lou Lou Ala Ile Lou Val Glu Asn Trp His Ser His Thr Ala tAu Asn Lys 236
GAA GCC TCG GCA GAT GTG GCT GAA CCG AGC TOG AGC CAA CAG ATG TGT CAG CCA GGA TTG ACC TTT GCA CGA ACA CCA AGT GTC TGC AAG
￿
90o
Glu Ala Ser Ala Asp Val Ala Glu Pro Ser Trp Ser Gln Gln Met Cys Gln Pro Gly Leru Thr Phe Ala Arg Thr Pro Ser Val Cys Lys 266
TARP.CACCTGGAGGTGAAGGCAGAGAGGAGCCAGGACTGTGOAGTCCGACAAAGCT
￿
~TCT 1019
AGACAGAGTCTGGCTCTGTCACCCAGGCTGAAGTGCAG~CGGCTGTTGAAC
￿
TTCTTG~CGWGTAGCTGGMTTACAGGC 1138
ACATACCACTGCACCCAGCTAATTTTTGTATTTTTAGTAGAGATGGGOITTCACTGTGTTGGC
￿
CTG(L%CC'TChOGTGATCCACCCACCTTGGCCTCCCAAA 1257
GTGCTGAGATTATAGGCATGAGCCACCACGCCTGGCCAGATGCATGTTCAAACCAATCAAATGGTGTTTTCTTATGCAOGACTGhTCGATTTGCACCCACCTITCTGCACATAAGTTAT 1376
GGTTTTCCATCTTATCrGTCTTCTGATTTTT'TATATCCTGTTTAATTTCTTCCTTCATTGTTCITCTCrrmIRTATTTATTTTATTTATTTTTATTTTTAI'1R"iTATTTGAGACAGAG 1495
TCTCACTCTGTTGCCCAGGAGGCGGAGGTTGGWTGAACCAAGAGATGGCGCCAGTGCACTCCACCCrGGG7GACAGX.,AGACTCTTfCT1TiT
￿
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Figure 3.
￿
Human FcaR cDNA. (A) Restriction map and schematic representation of FcaiR. Restriction sites are indicated for the enzymes Bg11l
(B), Clal (C), HindII1(H), and PstI (P). The boxed coding region depicts the predicted domain structure, including signal sequence (stippled), extracel-
lular (crosshatched), transmembrane (black), and intracellular (white) domains. (B) Human FcaiR nucleotide and predicted amino acid sequences. Nucleo-
tides are numbered beginning at 5' terminus, and amino acids are numbered beginning with the predicted NH2 terminus (Gin 22) of mature FC«R,
which is marked with an arrowhead. Cysteine residues are boxed and potential Winked glycosylation sites are marked with an asterisk. These sequence
data are available from EMBL/Gen Bank/DDBJ under accession number X54150.
OE (Fig. 2 A), whereas control COS cells did not (Fig. 2
F). This activity was completelyinhibited by the My43 mAb
(Fig. 2 B) and human IgA (Fig. 2 C), but not by human
IgG (Fig. 2 D). In a separate experiment, the inhibitory effects
of My43 and human IgA were found to be dose dependent
(Table 1). As a further indication of target specificity, the
FcaRtransfected COS cells failed to form rosettes with human
IgG-coated OE (Fig. 2 E and Table 1). Thus, the recombinant
receptor is capable of initiatingthe first step in IgAmediated
Expression Cloning of a Human Fc Receptor for IgA
immune effector functions, i.e., specific binding of IgAcoated
targets.
The structural features of the 1.6-kb cDNA insert in
pHuFccfR were determinedby restriction endonuclease map-
ping (Fig. 3 A) and nucleotide sequence analysis (Fig. 3 B).
The pHuFcciR cDNA is composed of a 39-bp 5' untrans-
lated region, a 861-bp open reading frame, and a 711-bp 3'
untranslated region terminating in a poly-A tract. The 3' re-
gion also includes an Alu-sequence (1020-1296) (referenceFcrRlll
FCER1
IB
1M
EC,aVRTEDLPKAVVFLEPQWY8VLEKD8RT
EC, HIaW----LLLQAPRWV-FKEEDPIH
EC, VLAVPQKPKVBLNPPWNR1FKaENRT
EC, FBDWLL-LQA8AEVVMEaQPLF
DHMDA KA
OPVDL V
TSAOV~
LTARRE
KANN-
28) and ATrich stretches, but lacks a polyadenylation signal.
The open reading frame encodes a protein of 287 amino acids,
the first 21 amino acids of which exhibit characteristics of
a hydrophobic signal sequence (29). Thus, the predicted ma-
ture receptor sequence would begin at Gln22, resulting in
a peptide of predicted M, -29,900, a value that is consis-
tent with the reported molecular mass (32-36 kD; reference
13) of deglycosylated U937 FcaR. The 206-amino acid ex-
tracellular domain includes six potential sites for --linked
glycosylation, a feature that along with O-glycosylation could
account for the significantly higher molecular mass, -60 kD,
observed for native FcaR.
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ao
￿
40
QAIREAYLTQLMIIKN19TYRE
88AHIPF-DRFBLAKE EL8-
EVLHLPd688TQWFLL1VdTATQ
ETKLLLQRPOLQLYFSFYMaS
QaAR8PE8D8 1 QWFHNtINL I P
HSWKDKPLVKVTFFQNO 8QK
QOAYSPEDNSTQWFH EOL18
SWKNTALHKVTYLQ ' G DRK
(INNFFEV88TKWFH aSLSE
OWRNWDVYKV1YYKD EALK
YOWYNRBPYLWOFPONALELV
R(IL8(IR---- BDPIQ-LEIH
EAATEDONVLKRSPELE
TOQTSLSDPVHLT
TONIOYTLF88KPVTIT
TNLSTLODPVQLEV
-ROLVaSKNV88ETVNIT1TQaLAV
HQQVNESEPVYLEV
TOKVWQLDYESEPLNITVIKAPREK
Table 2.
￿
Alignment Scores and Percent Sequence Identityfor the Ig Fc Receptor Family
Figure 4.
￿
AlignmentofFWRIg
domains. Boldresiduesindicatecon-
served residues typical ofIg family
members; boxed residues indicate
FcoiR domain residues common
withfive other FcR domainsin this
alignment; numbers indicate loca-
tion of residues in the FcaR se-
quence. EC, and EC2 denote first
andsecond extracellular domainsof
the indicated FcR protein.
When the amino acid sequence for the extracellular re-
gion was compared with existing protein sequence databases
using the FASTA algorithm (30), homology was found with
the other Ig Fcks sequenced to date. Further analysis of the
FcR sequences using the NBRF program ALIGN (23) re-
vealed statistically significant alignmentsbetween the FcciR
and other members of this receptor family. Most notably,
the FcceR appeared, as do the other FcRs, to contain several
conserved residues that are the hallmarks ofIg-like sequences
(31) in two contiguous domains. These residues, including
the two cysteines in each domain that form the disulfide bond
that holds together the Ig fold (31), are indicated in an align-
Scores aretheSD forthe indicated pair of alignedsequences (top) vs. theaverage scores from 100randomized alignments ofthesame pair of sequences
(bottom).
Sequence
FCaRI
EC, EC2 EC,
FcykI
EC2
FcyRII
EC, EC2
FCyRIII
EC, EC2
FCC-Rl
EC, EC2
FcciRI EC, - 7.0 3.4 4.1 4.5 5.5 4.6 3.6 2.4 3.1
EC2 23.2 - 4.8 5.2 5.1 4.2 4.0 3.5 3.6 2.6
FcyRI ECr 22.4 24.7 - 4.8 15 .9 5.2 14.6 4.6 15.3 3.2
EC2 22.8 21.7 25.9 - 4.9 4.2 5.3 3.1 5.3 4.6
FcykII EC, 24.1 25.3 49.4 26.5 - 6.0 17.2 5.6 13.0 3.4
EC2 20.0 28.2 28.2 18.8 24.1 - 4.7 17.1 3.9 13.7
FcyRIII EC, 28 .2 21 .2 49.4 28.2 55.4 21 .2 - 4.5 12.3 3.1
EC2 18.2 20.5 27.1 18.2 25 .3 45.9 22.4 - 4.3 13.1
FceRI EC, 17 .6 24.7 38.8 27.1 43 .4 23 .5 43.5 25.9 - 3.3
EC2 19.6 25.0 22.4 20.7 24.1 36 .6 25.9 42.0 28 .2 -
FcaRl
EC, IORRLKFWNETDPEFVI
EC, LPQHQS--(1EHPANFS
EC, ---------TOTPOY
FcrRl KTLR---GRNT88EYQQU EC,
FcrRll
EC, --------THTQPSYR
EC, -FBRL------DPTFB 1
EC, ---------OQASOYFII FcrR111
EC, -------YFHHNBDFH
EC, ---------ETNOOLN 1
FcERI
EC, -------YWYENHNIS 1
FcaRl
EC, QEaDFPMPFISAK88PVIPLDaO
EC, VTaLYaKPFL8ADRaLVLMP(IE
FcrR1
EC, QVDTTKAVIBLQPPWVSVFQEET
EC, VKELFPAPVLNAOVTOPLLECINL
FcrRll
EC, AAAPPKAVLKLEPPW1NVLQEDB
EC, VLBEWLV--LQTPHLE-FQEaEment oftheFcR sequences in Fig . 4 . Given the conservation
of Ig domain structure, it is likely that Cys 28 is disulfide
bonded to Cys 79 in domain 1, and Cys 125 and Cys 172
are paired in domain 2 (shown as boxed residues in Fig . 4).
The resultingALIGN scores from the alignment are shown
in Table 2 . It is clear from these alignments that although
Figure 6 .
￿
Autordiogrun ofhy-
bridizationofF=RcDNA probe
to Southern blot of human
genomic DNA. Genomic DNA
was digestedwith EcoRl (lane 1),
HindIII (lane 2), BamHI (lane 3),
Pstl (lane 4), or BglII (lane 5) .
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Figure 5 .
￿
Autoradiogram of hybridization
ofF=R to Northern blot of human myeloid
and lymphoid cell mRNA . Polyadenylated
RNA was analyzed from the following cells:
(lane 1) 12-h PMAstimulated U937; (lane 2)
unstimulated U937; (lane 3) neutrophils; (lane
4) peripheralblood monocytes; (lane5)PWM-
stimulated tonsillar B cells ; (lane 6) PMA/
ionomycin-treated tonsillar Bcells; (lane 7) un-
stimulated tonsillar B cells; (lane 8) PHA
stimulated tonsillar T cells; (lane 9) unstimu-
lated tonsillarTcells; and (lane 10) totalRNA
from human dermal fibroblasts.
the FcaR is homologous to the other known FcRs and is
more closely related to those proteins than to several other
members ofthe Ig superfamily, it is somewhat more distantly
related to other FcRs than are these receptors to each other .
Thus, it is likely that the FcciR diverged from a common
ancestor very early in the development of the Ig FcR gene
family. The existence ofa distinct family of FcRs is supported
by previous work demonstrating that the genes for FcyRI,
FcyRII, FcyRIII, and thea chain ofFceRI map to the long
arm ofchromosome 1(32, 33). We are currently investigating
the possibility that the FCaR, which shares structural and
functional qualities with these other FcRs, maps to the same
chromosomal region .
Hydropathicity analysis indicated that the extracellular re-
gion of the FcaR is followed by a 19-residue stretch of hy-
drophobic amino acids (Leu 207 to Val 225) corresponding
to a potential transmembrane region . The intracytoplasmic
region would thus be composed of41 amino acids. Two fea-
tures of the putative transmembrane region are atypical of
"protein anchored" transmembrane proteins, including the
presence of a charged residue (Arg 230) within the hydro-
phobic transmembrane domain and the lack of a cluster of
basic residues immediately following the hydrophobic stretch
(34) . A number of proteins containing a charged residue in
the transmembrane region have been reported to attach to
the membrane either through a glycosyl-phosphatidyl ino-
sitol (GPI) linkage (e.g ., the Qa-2 MHC antigen ; reference
35) or by association with another membrane-bound protein
(e.g., the TCR, which requires association with the CD3
complex for cell surface expression ; reference 36) . With re-
gard to Fc receptors, the a chain of the high affinity IgE
receptor (FceRI) contains an Asp residue in the transmem-brane region and is attached by the latter mechanism, i.e.,
through interaction with the y chain (37). The two genes
for human FcyRIII also include an Asp residue in the middle
of the membrane-spanning region (38). The FcyRIII isoform
expressedby PMNs is GPI linked (38, 39), while the isoform
expressed by NK cells and macrophages appears to require
an additional peptide for cell surface expression, a function
that can be provided by the y chain of the FteRI (40, 41).
The critical difference between these two isoforms appears
to reside in the presence or absence of a Ser 203 residue in
the extracellular region, which signals GPI attachment
(40-42). Although there is a Ser residue in an analogous site
of the FcciR (Ser 197), it is unlikely that FcoiR is GPI linked,
since Monteiro et al. (13) have shown that FcciR on human
monocytes, granulocytes, and U937 cells are resistant to
cleavage with GPI-specific phospholipase C (PLC). We have
made similar observations with these cell populations, and
also found that the level of expression ofFcciR on transfected
COS cells was unaffected by PLC treatment. The presence
of an associated protein cannot be ruled out, although results
with transfected COS cells would require such a protein to
be present in both myeloid cells and COS-7 cells. Clearly,
additional studies are required to determine the nature of FcaR
attachment and the possible relevance of the different forms
of membrane attachment of Fc receptor function.
Using an RNA probe representing the 5' untranslated re-
gion and coding sequence for a portion of the extracellular
region, we analyzed expression of FcctR mRNA (Fig. 5).
Two major hybridizing transcripts of -2.8 and -2.6 kb were
observed in polyadenylated RNA preparations from U937
cells, peripheral blood monocytes, and PMN. PMAstimulated
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immunoregulation of IgA synthesis.
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